Location History:
- Morristown, NJ (US) (2002)
- Winchester, MA (US) (2010 - 2015)
Company Filing History:
3 out of 3,539 
3 out of 3,923 
Years Active: 2002-2015
Title: Mary Ellen Digan: Innovator in Immunotoxin Fusion Proteins
Introduction
Mary Ellen Digan is a notable inventor based in Winchester, MA (US). She has made significant contributions to the field of immunotoxin fusion proteins, holding a total of 4 patents. Her work focuses on developing novel recombinant immunotoxins that have the potential to advance medical treatments.
Latest Patents
One of her latest patents is titled "Immunotoxin fusion proteins and means for expression thereof." This invention provides novel recombinant DT-based immunotoxins, specifically targeting anti-T cell immunotoxin fusion proteins. The patent details immunotoxins that can be expressed in various cell types, including bacterial, yeast, or mammalian cells. The invention also outlines methods for the expression of the immunotoxin fusion protein, ensuring compliance with technical disclosure requirements.
Career Highlights
Mary Ellen Digan has worked with prestigious organizations, including the National Institutes of Health, a component of the US Department of Health & Human Services, and Novartis AG. Her experience in these institutions has contributed to her expertise in the field of immunology and biotechnology.
Collaborations
Throughout her career, Mary Ellen has collaborated with notable colleagues such as David M Neville and Jerry Todd Thompson. These collaborations have likely enriched her research and innovation efforts.
Conclusion
Mary Ellen Digan's contributions to the field of immunotoxin fusion proteins demonstrate her commitment to advancing medical science. Her innovative patents and collaborations highlight her role as a significant figure in biotechnology.